These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 4790565)
41. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Miyashita N; Niki Y; Kishimoto T; Nakajima M; Matsushima T Antimicrob Agents Chemother; 1997 Jun; 41(6):1331-4. PubMed ID: 9174194 [TBL] [Abstract][Full Text] [Related]
42. [Comparison of the in vitro antibacterial activity of trimethoprim-sulfadiazine and trimethoprim-sulfamethoxazole combinations]. Thabaut A Therapie; 1983; 38(4):399-404. PubMed ID: 6606237 [No Abstract] [Full Text] [Related]
43. [In vitro and in vivo activity of spiramycine on Chlamydia (author's transl)]. Orfila J; Haider F; Thomas D Pathol Biol (Paris); 1982 Jun; 30(6):449-51. PubMed ID: 7050851 [TBL] [Abstract][Full Text] [Related]
44. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan. Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428 [TBL] [Abstract][Full Text] [Related]
45. Lymphogranuloma venereum. II. Characterization of some recently isolated strains. Schachter J; Meyer KF J Bacteriol; 1969 Sep; 99(3):636-8. PubMed ID: 4905529 [TBL] [Abstract][Full Text] [Related]
46. ALANINE: CYCLOSERINE ANTAGONISM. I. SIGNIFICANCE OF PHENOMENON IN TESTING SUSCEPTIBILITY TO CYCLOSERINE. HOEPRICH PD Am J Clin Pathol; 1964 Feb; 41():140-9. PubMed ID: 14124671 [No Abstract] [Full Text] [Related]
47. INHIBITION OF THE GROWTH OF AGENTS OF THE PSITTACOSIS GROUP BY D-CYCLOSERINE AND ITS SPECIFIC REVERSAL BY D-ALANINE. MOULDER JW; NOVOSEL DL; OFFICER JE J Bacteriol; 1963 Mar; 85(3):707-11. PubMed ID: 14042952 [TBL] [Abstract][Full Text] [Related]
48. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments]. Tsukamura M Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817 [TBL] [Abstract][Full Text] [Related]
49. Antibodies to Chlamydia species in patients attending a genitourinary clinic and the impact of antibodies to C. pneumoniae and C. psittaci on the sensitivity and the specificity of C. trachomatis serology tests. Moss TR; Darougar S; Woodland RM; Nathan M; Dines RJ; Cathrine V Sex Transm Dis; 1993; 20(2):61-5. PubMed ID: 8503060 [TBL] [Abstract][Full Text] [Related]
50. [A method for the determination of antibiotic sensitivity of chlamydias in vitro]. Henning K; Krauss H Zentralbl Veterinarmed B; 1986 Aug; 33(6):447-61. PubMed ID: 3788356 [No Abstract] [Full Text] [Related]
51. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. Madico G; Quinn TC; Boman J; Gaydos CA J Clin Microbiol; 2000 Mar; 38(3):1085-93. PubMed ID: 10699002 [TBL] [Abstract][Full Text] [Related]
52. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo. Johannisson G; Sernryd A; Lycke E Sex Transm Dis; 1979; 6(2):50-7. PubMed ID: 494040 [TBL] [Abstract][Full Text] [Related]
53. Synergic activity of D-cycloserine and beta-chloro-D-alanine against Mycobacterium tuberculosis. David S J Antimicrob Chemother; 2001 Feb; 47(2):203-6. PubMed ID: 11157908 [TBL] [Abstract][Full Text] [Related]
54. Inducible resistance to D-cycloserine in Bacillus subtilis 168. Clark VL; Young FE Antimicrob Agents Chemother; 1977 May; 11(5):871-6. PubMed ID: 406831 [TBL] [Abstract][Full Text] [Related]
55. Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis. Smelov V; Krylova T; Smelova N; Norman L Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S79-82. PubMed ID: 15037332 [TBL] [Abstract][Full Text] [Related]
56. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to sulfadiazine, sulfisoxazole and sulfathiazole. Casal M; Rodriguez F Eur J Clin Microbiol; 1984 Aug; 3(4):320-1. PubMed ID: 6489322 [No Abstract] [Full Text] [Related]
57. How useful is the Chlamydia micro-immunofluorescence (MIF) test for the gynaecologist? Wagenvoort JH; Koumans D; van de Cruijs M Eur J Obstet Gynecol Reprod Biol; 1999 May; 84(1):13-5. PubMed ID: 10413220 [TBL] [Abstract][Full Text] [Related]
59. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Kuo CC; Wang SP; Grayston JT Antimicrob Agents Chemother; 1977 Jul; 12(1):80-3. PubMed ID: 883821 [TBL] [Abstract][Full Text] [Related]
60. [The replication cycle of Chlamydia trachomatis and Chlamydia psittaci: ultrastructural analysis]. Falcieri E; Cevenini R; Landini MP; Donati M Boll Ist Sieroter Milan; 1979 Nov; 58(5):395-405. PubMed ID: 553521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]